The Amsler grid is a simple tool for monitoring vision in conditions like age-related macular degeneration (AMD). It helps detect distortions and visual impairment, allowing for timely intervention.
AMD
If you have AMD, you should inform your family, educate yourself, monitor for progression, make lifestyle modifications, and understand available treatments for AMD – early detection and intervention are crucial.
Studies showed anti-VEGF injections in wet AMD didn’t increase the risk of developing glaucoma, but people with both wet AMD and glaucoma had an elevated likelihood of visual field progression.
Myopic macular degeneration (MMD) is not the same as age-related macular degeneration (AMD). MMD primarily affects younger individuals with high myopia.
Explore the roles of optometrists and retina specialists in the diagnosis and management of macular degeneration, and learn how to navigate the landscape for better eye care and vision.
A bloodshot eye, also known as a subconjunctival hemorrhage, is a medical condition in which there is bleeding in the white part of the eye. (Warning: The following page contains a photo of a bloodshot eye that may be disturbing to some viewers. Viewer discretion is advised)
Learn about the non-surgical and surgical options available to manage presbyopia when you also have a retinal condition.
Age-related macular degeneration is a progressive eye disease that is commonly known as just macular degeneration or AMD. The condition occurs due to the deterioration or damage of the retina, which is the light-sensitive tissue located at the back of the eye. Because AMD is a disease that typically develops as a person ages, it is referred to as age-related macular degeneration. As people are now living longer, the number of individuals affected by this condition is also increasing.
SYFOVRE (pegcetacoplan injection) is now FDA approved for treating geographic atrophy (GA) in people with age-related macular degeneration.
Dry age-related macular degeneration (Dry AMD) is a common eye condition that affects people over the age of 50. It is a chronic condition that causes the cells in the retina to slowly deteriorate, leading to blurred or reduced central vision. Learn more about the condition and the treatment available.
